Cytochrome P450 (CYP) 2El is a phase I enzyme. CYP2E1 RsaI polymorphism consists of wild CC genotype, heterozygous CT genotype, and homozygous mutation TT genotype, which is caused by the
C-T replacement in 5′ regulatory region. Studies show that the CYP2El
RsaI polymorphism is closely related to the susceptibility to lung cancer, but results are not consistent.
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Glutathione S-transferase (GST) is a phase II enzyme. The unequal exchange of homologous chromosomes in the highly homologous region of the glutathione S-transferase M1 (GSTM1) gene leads to the loss of 15KB bases, forming the GSTM1 ± polymorphism; this polymorphism includes the function type GSTM1 (+), and the homozygous deletion genotype
GSTM1 (−).
7 GSTM1 gene polymorphism can change the ability of the enzymes' activation or deactivation of the heterologous substrate, which can affect individual susceptibility to lung cancer after exposure. [8] [9] [10] [11] Previous studies somehow identified the functional role of CYP2E1 or GSTM1 polymorphism and lung cancer risk; several studies also showed the synergistic interaction between gene polymorphisms and environmental cancerogens, 12 and gene-gene interaction among metabolic enzyme genes, 13, 14 but interactions between CYP2E1 and GSTM1 polymorphism, these polymorphisms and environmental factors have seldom been reported, 15 and the results of these studies are not consistent. Besides, lung cancer ranks the first both in incidence and mortality rates of cancer in Zhejiang Province in recent years. It is necessary for us to carry out a case-control study in an enlarged sample size of subjects in order to further explore the variance of heredity and to assess the linkage between CYP2E1, GSTM1 polymorphisms, and lung cancer risk. Besides, synergetic interaction between genotypes and potential risk factors (such as smoking and alcohol intake) and gene-gene interaction also need to be estimated.
The multivariate logistic regression analysis model was used to analyze the independent effect of gene polymorphisms (CYP2E1 RsaI polymorphism and GSTM1 polymorphism) on lung cancer risk, as well as the combined effects of gene loci. The stratification analysis of age, sex, smoking, and drinking combined with positive loci was also analyzed, and the interaction was identified to provide the basis for exploring genetic susceptibility markers for lung cancer.
| OBJECTS AND METHODS

| Objects
The patients with lung cancer were recruited from various above The CYP2E1 RsaI polymorphism and GSTM1 polymorphism were detected through PCR and sequencing analysis on the blood samples.
The demographic data, smoking history, and drinking history of the subjects were also collected. Smoking was defined as smoking at least 1 cigarette a day for 6 months (whether continuous or accumulated) and currently still smoking. Drinking was defined as drinking any form of liquor at least once per week (whether continuous or accumulated) and currently still drinking. The differences in the age and sex between the 2 groups were not significant.
| Methods
| DNA extraction and quality control
DNA of the blood samples was extracted using the QIAamp DNA Blood Mini Kit (Qiagen, Düsseldorf, Germany). NanoDrop ND-1000
(Thermo, Wilmington, USA) was used to measure the concentration and quality of DNA.
| Genotyping
Pcr PCRs were performed after DNA quality inspection ( was used.
Sequencing
CYP2E1
RsaI genotyping was performed through sequencing analysis, using the products recovered by the purified and recovered PCR kit.
The ABI 3730XL automatic sequencing instrument (ABI) was used. (item SM0331; BBI, Markham, Canada) was used as a Marker ladder.
| Data analysis
All data were analyzed using SPSS 13.0 software. The univariate logistic regression analysis, stratification analysis, and interaction analysis were performed to assess associations with age, sex, smoking, drinking, and genetic polymorphisms (multicategorical variables transformed into dummy variables) between the cases and controls, and group variable (cases = 1, controls = 0) was used as the dependent variable (sls = 0.1, sle = 0.05).
| RESULTS
| CYP2E1 RsaI genotyping
The CC, CT, and TT genotype of CYP2E1 RsaI is as shown in Figure 1 .
| GSTM1 genotyping
The fragment of internal control β-globin was 268 bp in length, whereas the amplified gene products of GSTM1 were 215 bp.
If there is a 215-bp electrophoretic fragment, it is GSTM1 (+); if
there is no 215-bp fragment, it is GSTM1 (−). The 268-bp fragment of β-globin gene is required to be observed for each sample (Figure 2 ).
| Genotype distribution and logistic regression analysis on genetic susceptibility to lung cancer
The genotype distribution of CYP2E1 RsaI was in accordance with the Hardy-Weinberg equilibrium.
After logistic regression analysis, we found that:
1. For the CYP2E1 RsaI polymorphism, both lung cancer cases and healthy controls were dominated by the CC genotype, and the difference of genotype distribution between the 2 groups was statistically significant (χ 2 = 7.025, P < .05); compared with CC/CT, patients who were homozygous for the mutant allele (TT) had a significantly lower risk of lung cancer (OR = 0.24, 95% CI = 0.07-0.76, P = .015).
2.
For the GSTM1 allele polymorphism, both lung cancer cases and healthy controls were dominated by the GSTM1 (+) genotype, and the difference of genotype distribution between the 2 groups was statistically significant (χ 2 = 4.986, P < .05); compared with GSTM1
The CC, CT, and TT genotypes of CYP2E1 RsaI
The electrophoretic results of PCR products of GSTM1 and β-globin gene. M: DNA Marker D2000; 1, 4: GSTM1 (+); 2: β-globin; 3: GSTM1 (−) (+), GSTM1 (−) had a significantly lower risk of lung cancer(OR = 1.62, 95% CI = 1.02-2.57, P = .040). See Table 2 .
| The genes' associations and genetic susceptibility to lung cancer
The relationships between the risk alleles of CYP2E1 RsaI, GSTM1, and susceptibility to lung cancer were analyzed ( Table 3 Table 3 .
| Stratification analysis of the GSTM1 polymorphism and susceptibility to lung cancer
Age, sex, smoking, and drinking were layered, and the relationship between GSTM1 polymorphism and lung cancer risk in various layers was subsequently explored ( Table 4 ). The results showed that in female, nonsmoking, or nondrinking subjects, and the GSTM1 gene could increase the risk of lung cancer. Besides sex, no heterogeneity differences were found among various layers (P > .1).
| The interaction between the GSTM1 polymorphism and sex, smoking status, and susceptibility to lung cancer
The stratification analysis showed that there may be interaction between sex and the GSTM1 polymorphism. So the interaction between the GSTM1 polymorphism and sex, smoking status and susceptibility to lung cancer was further analyzed by adding the interaction item "GSTM1 polymorphism* sex" or "GSTM1 polymorphism* smoking status." But no interactions were found (both P > .05). Setting GSTM1 (+)
and male subjects as the reference, female, GSTM1 (−) subjects had a significantly increased risk of lung cancer, with an adjusted OR of 2.17 (95% CI = 1.01-4.70). Meanwhile, there were no significant differences in lung cancer risk in other groups (Table 5 ). When setting GSTM1 (+) and non-smoking subjects as the reference, lung cancer risk increased significantly in smoking, GSTM1 (+) genotype subjects and smoking, GSTM1 (-) subject, with adjusted ORs of 2.00 (1.01-3.96) and 2.89 (1.28-6.54) respectively; there were no significant differences in lung cancer risk in GSTM1 (+), non-smoking group (Table 6 ).
| DISCUSSION
CYP2E1 RsaI polymorphism is located in the 5′ regulatory region.
Chlorzoxazone was used as phenotypes of CYP2E1 metabolic substrates by Lucas et al, and they confirmed that subjects carrying the mutant RsaI allele showed lower basal activity of CYP2E1. They also showed that CYP2E1 activity could not be induced by ethanol, which suggested that RsaI polymorphism is closely related to the transcription, and thus affected the enzyme activity. 16 It has been confirmed that the distribution of CYP2E1 polymorphism differs among races. T A B L E 2 Logistic regression analysis of genetic polymorphism and susceptibility to lung cancer 2 groups-the homozygous mutant (c2/c2 (TT)) in the control group was 6.9%, but in patients with lung cancer, it was only 0.8%. Zhang's study 3 
on Mongolian and Han populations in the Inner Mongolian
Region showed that c1 compared c2 with the OR = 1.382, 95% CI = 1.178-1.587, P = .003. Our study also showed that the frequency of TT of CYP2E1 in patients with lung cancer was significantly lower (2.2%) than the control group (6.4%), and that the risk of lung cancer in homozygous mutant (TT) patients was significantly lower (OR = 0.24, 95% CI = 0.07-0.76, P = .015) compared with CC and CT. But the results were inconsistent with Wang in Guangzhou. 4 There are also different reports on the white. 6 Studies in a Swedish population showed that the c2 allele of CYP2E1 has a protective effect. 5 GSTs family is involved in biological metabolism of the phase II enzyme system in vivo, converting the activated and electronically additionally, smoking subjects who carrying GSTM1 deficient would have an increased risk of lung cancer. This phenomenon could be explained by the fact that some procarcinogens (such as polycyclic aromatic amines (PHA) in cigarettes, 27 4,5 epoxidation benzo a pyrene (BaPo) 28 ) that are activated by phase I metabolic enzymes are substrates of GSTM1; GSTM1 plays an important role in the metabolic inactivation of these carinogens. 29 GSTMl (−) could not produce enzyme activity, and thus, metabolic inactivation was low, which resulted in increased lung cancer patients with GSTMl (−).
Our study also suggests that women with GSTM1 defect type had a higher risk of lung cancer. Therefore, GSTMl (−) carriers should reduce the exposure of environmental carcinogen.
The mechanisms of environmental carcinogens are complex, and the real effect substrate and the mechanism of many metabolic enzymes were not very clear, which lead to the difference of the risk of gene polymorphism of these metabolic enzymes on tumors. At the same time, due to the differences of ethnicities, individuals, sample size, the intensity of carcinogen exposure, region, and research methods, different or even conflicting results were resulted on metabolic enzyme gene polymorphism and tumor susceptibility. Therefore, further research is needed to solidify the relationships between and mechanisms underlying gene polymorphisms and lung cancer susceptibility.
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